EPISODE · Jan 11, 2024 · 43 MIN
J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio
from Touching Base
Episode 4 (January 12, 2024): Takeaways from the J.P. Morgan Health Care conference: Illumina, Danaher, 10x, Empress Therapeutics; an interview with Liberate Bio’s Shawn Davis and Walter Strapps. Listed below are references to relevant GEN stories discussed in this episode of Touching Base: JPM: Illumina’s new CEO spells out 2024 priorities, presents preliminary Q4 2023 results By Alex Philippidis, GEN, January 10, 2024. JPM: Prime Medicine eyes 2024 IND for first prime editing therapy By Alex Philippidis, GEN, January 9, 2024 JPM 2024: Veracyte’s C2i genomics acquisition adds AI readouts to liquid biopsy testing By Jonathan D. Grinstein, GEN, January 8, 2024 JPM: More M&A “firepower” in store for 2024, EY predicts By Alex Philippidis, GEN, January 8, 2024 Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio
No transcript for this episode yet
Similar Episodes
May 21, 2026 ·54m
May 15, 2026 ·54m
May 11, 2026 ·31m
May 11, 2026 ·109m
May 9, 2026 ·23m
May 7, 2026 ·54m